Connection

Saul Faust to Measles-Mumps-Rubella Vaccine

Back to Details
This is a "connection" page, showing publications Saul Faust has written about Measles-Mumps-Rubella Vaccine.
Saul Faust
Connection Strength
0.141
Measles-Mumps-Rubella Vaccine
  1. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK. Vaccine. 2018 04 19; 36(17):2300-2306.
    View in: PubMed
    Score: 0.141
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.